Blast and cruise is the modern answer to the PCT question: instead of cycling off and gambling on recovery, stay on a TRT-grade cruise between growth phases. It trades acute post-cycle crashes for chronic, low-grade physiological adaptation. Neither choice is free; they simply bill you differently. This article is what five years of B&C actually looks like in blood work: which markers stabilize, which ones creep, and which ones quietly become permanent.
The biggest practical mistake in year one is cruise dose drift. Guys start at 150 mg, feel good, then nudge to 200 mg because the gym session was flat. By month six they are running 250 mg and calling it a cruise. That is a blast in disguise. The bloodwork gives it away: hematocrit sits above 52%, HDL is down 25% from baseline, and E2 needs an AI. A true cruise dose should hold your total testosterone in the 700-900 ng/dL range on a trough draw. If you need more than that to feel human, the problem is not your testosterone, it is your recovery, sleep, or stress management. Lock the dose, log it, and do not touch it for at least six months.
The First Year: The Baseline Reset
The first blast-and-cruise year is physiologically the most eventful. HPTA suppression becomes continuous rather than cyclical: LH and FSH flatline and stay flatlined, testicular volume falls, and natural testosterone production, the thing PCT tries to rescue, becomes functionally irrelevant to your blood levels. Endogenous T falls toward zero and stays there. This is the intended trade: you are now permanently exogenous.
The markers that reset in year one: hematocrit climbs to its new plateau, typically 48-52% on a 150-200 mg cruise, E2 settles at cruise-dose-dependent levels, and SHBG falls, which is why cruise-phase free testosterone often looks better than total T suggests. The markers that begin their slow work in year one, quietly: lipids shift to their suppressed-but-stable state, and the cardiac remodeling clock starts. Nothing here is dramatic. All of it compounds.
Ferritin is the silent casualty of the donation schedule. Every therapeutic phlebotomy pulls 200-250 mg of iron out of you. On a 5-year B&C timeline, guys who donate every 8-12 weeks to keep hematocrit under 52% often end up with ferritin below 30 ng/mL, sometimes under 20. That is functional iron deficiency even with a normal hemoglobin. Symptoms show up as fatigue, brain fog, and a sudden drop in endurance that you will blame on the blast. The fix is not to stop donating, it is to track ferritin every 6 months and supplement with 20-30 mg of elemental iron daily if it dips below 40. Recheck in 3 months. If ferritin stays low despite supplementation, you are donating too often or your dose is too high. Adjust the cruise, not the donation.
LH + FSH
Hematocrit
The Slow Trends That Do Not Reset
Three trends matter over a five-year horizon precisely because each individual year looks unremarkable. First, lipids: cruise-phase HDL runs 10-20% below natural baseline indefinitely, and the years spend more time at that plateau. The cardiovascular cost of B&C is not any single bad number, it is the area under a decade-long curve. Second, hematocrit drift: what was 48% at year one tends to be 50-51% at year three as iron kinetics and plasma volume find their long equilibrium, pushing more B&C veterans into donation schedules. Third, and most underrated: the heart. Echocardiographic studies of long-term AAS users show left ventricular mass creeping upward with cumulative dose-years. Silently, because LVH has no blood marker, only imaging.
HDL is the headline, but ApoB is the story. A 5-year B&C panel will show HDL 10-20% below baseline, but that number alone understates the risk. The real driver of atherosclerosis is the number of LDL particles, and ApoB is the best proxy. On a cruise, ApoB often runs 20-30% above natural baseline even when LDL cholesterol looks borderline. On a blast, it can jump 40% or more. If your ApoB sits above 100 mg/dL on cruise, you are accumulating arterial damage that HDL cannot offset. The practical response is not to panic, it is to measure ApoB at every annual draw and keep it under 90. If it creeps up, lowering the cruise dose and adding 2-3 grams of omega-3s daily are self-directed first steps; whether a statin is warranted on top of that is a licensed medical professional's call. That is a conversation worth having before year three.
The fourth trend is procedural rather than physiological: PSA. On a permanent-androgen protocol, prostate monitoring stops being optional at year two, not year fifty. PSA in the 1-2 ng/mL range is typical on B&C; the number that matters is your own trend. A PSA that moves from 1.2 to 2.4 across two years is a conversation with a urologist, regardless of both values being individually "normal.
PSA (Prostate-Specific Antigen)
HDL Cholesterol
What Each Phase Costs
The blast is where B&C pays its acute tax. At 500-750 mg+ of total androgens, expect HDL to fall another 20-30% from cruise baseline, hematocrit to push 2-4 points, BP to rise with the water load, and liver values to wobble if orals are in the mix. A well-run blast returns to cruise baseline within 6-10 weeks of ending. The cruise is where B&C pays its chronic tax, which means permanently suppressed lipids, permanent hematocrit management, and the quiet accumulation of dose-years on cardiac structure.
Blast hematocrit management is a hydration game, not a donation game. At 500 mg of testosterone, your RBC mass expands within 3-4 weeks. Donating during a blast is counterproductive because it drops your hematocrit temporarily, but the erythropoietin stimulus is still high, so you rebound fast and lose iron. Instead, front-load the hydration: 4-5 liters of water daily, plus electrolytes, and keep sodium moderate. That alone can shave 2-3 points off the hematocrit reading. Also, check your hematocrit at the same time of day, ideally after a rest day, because acute exercise and dehydration spike it. If hematocrit still pushes 54% on a blast, cut the dose or end the blast early. The heart does not care about your cycle goals. A 5-year horizon means you will have many more blasts. Do not sacrifice the long game for one short one.
🫀The five-year B&C panels that look best tend to share one pattern: short blasts (8-12 weeks), conservative cruise doses (150-200 mg testosterone equivalent), and at least one honest recovery-style draw per year with lipids, CBC, PSA, and a cardiac checkpoint. The drug schedule is the variable you control; the trend lines are the bill.
Year-5 B&C Markers: Cruise vs Blast
| Marker | Marker | What five years shows |
|---|---|---|
| Testosterone | Cruise 800-1200 ng/dL • Blast 1500-3000+ | Endogenous production: zero, permanently |
| Estradiol | Cruise 25-45 • Blast 50-80 pg/mL | AI use on blasts is the #1 source of crashed E2 visits |
| Hematocrit | Cruise 48-52% • Blast 52-55% | Donation/phlebotomy schedule becomes routine for many |
| HDL | Cruise: -10-20% vs baseline • Blast: -30-50% | Recovers to cruise floor between blasts, never above it |
| PSA | 1-2 ng/mL typical | Velocity, not absolute value, is the signal |
| LVH (imaging) | Creeps with cumulative dose-years | No blood marker — annual/echo if long-term plan |
The B&C Yearly Panel: What to Draw and When
Once you're on permanent exogenous testosterone, the monitoring calendar shifts. Quarterly blood draws belong to blast phases. During cruise, you run one comprehensive annual panel and add targeted mid-year checks. That's the schedule that holds up over a 5-year horizon.
Annual Full Panel (Cruise Phase)
Your year-over-year trend file covers total and free testosterone, an E2 sensitive assay, CBC with hematocrit, full lipids plus ApoB/ApoA1, ALT/AST/GGT, cystatin C, PSA, ferritin, and HbA1c. Draw it in the same calendar month each year, at least 8 weeks after any blast ended, so the numbers are comparable.
The annual draw is only as good as its conditions. Draw in the same calendar month, but also the same time of day, after a 12-hour fast, and at least 8 weeks after any blast. That last point is the one guys skip. If you ended a blast 6 weeks ago, your lipids and hematocrit are still elevated, and your E2 is still settling. The result is a false baseline that makes your cruise look worse than it is. Also, do not train the morning of the draw. A heavy session can raise creatinine and CK, and it can shift hematocrit by 1-2 points. And for testosterone, draw at trough, meaning right before your next injection. That gives you the true floor. If you inject twice a week, draw on the morning of the injection day. Consistency beats precision. The trend is what matters, and trends only show up when the conditions are identical.
Mid-Year Compact Check
Run the CBC, hematocrit, and ferritin panel six months after your annual draw. That timing catches the hematocrit creep and iron depletion that a regular donation schedule sets in motion, and it's the one that keeps you from getting blindsided at the end of the year.
Blast Entry and Exit Draws
Get your Lipids, CBC, and E2 drawn at blast start so you can measure the blast against your own cruise floor. Repeat the exact same panel 8 weeks after blast end to confirm you've truly returned to that floor. The exit draw is the one that catches blasts that never quite ended: cruise doses that drifted up, esters that lingered.
The exit draw 8 weeks after blast end is the one that catches the slow bleed. If your cruise dose is 150 mg, your total testosterone should be back in the 700-900 ng/dL range, and your hematocrit should be within 1-2 points of your pre-blast cruise value. If it is not, the blast never really ended. The most common cause is a cruise dose that drifted up during the blast, because guys get used to the higher dose and do not drop back to the original number. Another cause is an oral that lingered in the liver, especially if you used something like anavar or winstrol. Check your ALT and GGT on that exit draw. If they are still elevated, give it another 4 weeks and recheck. If the numbers do not normalize, you are not on a cruise, you are on a low-dose blast. Fix the dose before the next cycle, not after.
Yearly Cardiac Checkpoint
Keep a BP log and review it regularly. On top of that, get an echocardiogram at least every 2 to 3 years starting from year three of being on. LVH is the five-year marker that blood work can't see. If imaging shows a growing LV mass trajectory, that's the single strongest argument you'll get for shorter blasts and lower cruises, and it shows up years before any symptoms do.